Ftse Mib
37.068,68
-0,14%
DAX
21.931,66
0,09%
S&P 500
6.083,57
0,36%
NASDAQ
19.791,99
0,51%
Bitcoin
97.621,46
1,08%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TELA Bio Inc (TELA) TELA Bio Inc (TELA) Notizie

TELA Bio Inc

TELA
2,76
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:09:50
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/1/202522:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
13/12/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
19/11/202422:05GLOBETELA Bio to Participate in Piper Sandler’s 36th Annual..
07/11/202422:15EDGAR2Form 8-K - Current report
07/11/202422:05GLOBETELA Bio Reports Third Quarter 2024 Financial Results
01/11/202421:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
28/10/202421:06EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
24/10/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202422:05GLOBETELA Bio Announces Closing of Public Offering of Common..
23/10/202423:16EDGAR2Form 8-K - Current report
23/10/202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/10/202414:07GLOBETELA Bio Announces Pricing of Public Offering of Common..
22/10/202422:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/10/202422:05GLOBETELA Bio Announces Proposed Public Offering of Common Stock..
22/10/202422:01EDGAR2Form 8-K - Current report
17/10/202422:05GLOBETELA Bio to Announce Third Quarter 2024 Financial Results
13/8/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:15EDGAR2Form 8-K - Current report
12/8/202422:05GLOBETELA Bio Reports Second Quarter 2024 Financial Results and..
09/8/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
06/8/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202423:50EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
25/7/202422:05GLOBETELA Bio to Participate in the Canaccord Genuity 44th Annual..
22/7/202422:05GLOBETELA Bio to Announce Second Quarter 2024 Financial Results
10/6/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:55EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/6/202422:15EDGAR2Form 8-K - Current report
04/6/202422:05GLOBETELA Bio Appoints Jeffrey Blizard to its Board of Directors
20/5/202422:15EDGAR2Form 8-K - Current report
20/5/202422:03GLOBETELA Bio Appoints Greg Firestone as Chief Commercial Officer
10/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202422:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
09/5/202422:20EDGAR2Form 8-K - Current report
09/5/202422:05GLOBETELA Bio Reports First Quarter 2024 Financial Results
25/4/202413:00GLOBETELA Bio to Announce First Quarter 2024 Financial Results
15/4/202413:00GLOBETELA Bio Announces U.S. Commercial Launch of..
08/4/202413:00GLOBETELA Bio Welcomes Acclaimed Surgeon as Vice President of..
21/3/202421:05GLOBETELA Bio Achieves Record Fourth Quarter and Full Year 2023..
21/3/202412:00GLOBETELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the..
20/3/202412:00GLOBETELA Bio Announces Sale of Distribution Rights for Wound..
29/2/202413:00GLOBETELA Bio to Announce Fourth Quarter and Full Year 2023..
27/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 2,76

La tua Cronologia

NASDAQ
TELA
TELA Bio
LSE
KDNC
Cadence Minerals
AQSE
JET2.GB
JET2
COIN
PTTUSD
Proton Token
BIT
P1R9G0
BNP Paribas Issuance
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci